- Home
- KALA vs CLIR Comparison
KALA vs CLIR Comparison
Compare KALA & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- CLIR
- Stock Information
- Founded
- KALA 2009
- CLIR 2008
- Country
- KALA United States
- CLIR United States
- Employees
- KALA N/A
- CLIR N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- CLIR Industrial Machinery/Components
- Sector
- KALA Health Care
- CLIR Industrials
- Exchange
- KALA Nasdaq
- CLIR Nasdaq
- Market Cap
- KALA 26.2M
- CLIR 32.5M
- IPO Year
- KALA 2017
- CLIR 2012
- Fundamental
- Price
- KALA $5.16
- CLIR $0.54
- Analyst Decision
- KALA Strong Buy
- CLIR Strong Buy
- Analyst Count
- KALA 3
- CLIR 1
- Target Price
- KALA $14.00
- CLIR $2.00
- AVG Volume (30 Days)
- KALA 71.9K
- CLIR 49.5K
- Earning Date
- KALA 08-05-2025
- CLIR 08-13-2025
- Dividend Yield
- KALA N/A
- CLIR N/A
- EPS Growth
- KALA N/A
- CLIR N/A
- EPS
- KALA N/A
- CLIR N/A
- Revenue
- KALA N/A
- CLIR $2,895,000.00
- Revenue This Year
- KALA N/A
- CLIR $27.61
- Revenue Next Year
- KALA N/A
- CLIR $116.19
- P/E Ratio
- KALA N/A
- CLIR N/A
- Revenue Growth
- KALA N/A
- CLIR 10.88
- 52 Week Low
- KALA $2.92
- CLIR $0.46
- 52 Week High
- KALA $11.20
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- KALA 61.92
- CLIR 38.59
- Support Level
- KALA $4.36
- CLIR $0.50
- Resistance Level
- KALA $5.75
- CLIR $0.60
- Average True Range (ATR)
- KALA 0.53
- CLIR 0.06
- MACD
- KALA 0.07
- CLIR -0.01
- Stochastic Oscillator
- KALA 64.39
- CLIR 25.93
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.